Guggenheim Capital’s CAS Medical Systems, Inc. CASM Stock Holding History

Guggenheim Capital’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,246	Closed	-$15K	–	2750
2018 Q1	$15K	Buy	12,246 +74	+0.6%	+$83	﹤0.01%	2755
2017 Q4	$9K	Sell	12,172 -1,520	-11%	-$1.11K	﹤0.01%	2693
2017 Q3	$13K	Sell	13,692 -7	-0.1%	-$7	﹤0.01%	2773
2017 Q2	$16K	Hold	13,699	–	–	﹤0.01%	2797
2017 Q1	$20K	Buy	13,699 +1,182	+9%	+$1.8K	﹤0.01%	2788
2016 Q4	$20K	Hold	12,517	–	–	﹤0.01%	2851
2016 Q3	$21K	Sell	12,517 -194	-2%	-$337	﹤0.01%	2823
2016 Q2	$23K	Hold	12,711	–	–	﹤0.01%	2801
2016 Q1	$18K	Buy	12,711 +1,411	+12%	+$2.29K	﹤0.01%	2833
2015 Q4	$20K	Buy	+11,300	New	+$16K	﹤0.01%	2919

Other funds holding CASM

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Guggenheim Capital's CASM Position: Q2 2018 in Review

Guggenheim Capital sold out of CAS Medical Systems, Inc. (CASM) in Q2 2018, closing a stake of 12,246 shares — an estimated $15K sold.

Guggenheim Capital first reported a position in CASM in Q4 2015 and held it in 10 quarters. The position peaked at $23K in Q2 2016. 21 funds tracked by Wall St. Rank hold CASM as of Q2 2018.

Guggenheim Capital reported no remaining CAS Medical Systems, Inc. position as of Q2 2018 after selling out during the quarter.
Guggenheim Capital sold 12,246 CAS Medical Systems, Inc. shares in Q2 2018, an estimated $15K.
Guggenheim Capital first reported a position in CAS Medical Systems, Inc. in Q4 2015 and held it in 10 quarters.
Guggenheim Capital's CAS Medical Systems, Inc. position peaked at $23K in Q2 2016.
21 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.